rs727504318
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP3BP6
The NM_000256.3(MYBPC3):c.405A>G(p.Lys135Lys) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 1,404,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000256.3 splice_region, synonymous
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 4Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- left ventricular noncompaction 10Inheritance: AR, AD Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- atrial fibrillationInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000256.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYBPC3 | NM_000256.3 | MANE Select | c.405A>G | p.Lys135Lys | splice_region synonymous | Exon 3 of 35 | NP_000247.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MYBPC3 | ENST00000545968.6 | TSL:5 MANE Select | c.405A>G | p.Lys135Lys | splice_region synonymous | Exon 3 of 35 | ENSP00000442795.1 | ||
| MYBPC3 | ENST00000399249.6 | TSL:5 | c.405A>G | p.Lys135Lys | splice_region synonymous | Exon 3 of 34 | ENSP00000382193.2 | ||
| MYBPC3 | ENST00000544791.1 | TSL:5 | n.405A>G | splice_region non_coding_transcript_exon | Exon 3 of 27 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000303 AC: 5AN: 165108 AF XY: 0.0000335 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 25AN: 1404666Hom.: 0 Cov.: 31 AF XY: 0.0000230 AC XY: 16AN XY: 694970 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Lys135Lys varia nt (MYBPC3) has not been reported in the literature but has been identified in o ne individual with HCM by our laboratory. This variant is located in the last t hree bases of the exon, which is part of the 5? splice region. Computational too ls do not predict a strong effect on splicing; however, this information is not predictive enough to rule out pathogenicity. In summary, this variant is less li kely pathogenic but additional information is needed to fully assess its clinica l significance.
Hypertrophic cardiomyopathy Uncertain:1
This sequence change affects codon 135 of the MYBPC3 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MYBPC3 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs727504318, gnomAD 0.007%). This variant has been observed in individual(s) with clinical features of MYBPC3-related conditions (PMID: 28679633). ClinVar contains an entry for this variant (Variation ID: 177780). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Cardiovascular phenotype Uncertain:1
The c.405A>G variant (also known as p.K135K), located in coding exon 3 of the MYBPC3 gene, results from an A to G substitution at nucleotide position 405. This nucleotide substitution does not change the lysine at codon 135. This variant was reported in individual(s) with features consistent with hypertrophic cardiomyopathy (HCM) (Helms AS et al. Circ Genom Precis Med, 2020 Oct;13:396-405; Westphal DS et al. J Cardiovasc Dev Dis, 2022 Jan;9:[ePub ahead of print]). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site. Based on the available evidence, the clinical significance of this variant remains unclear.
Cardiomyopathy Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at